Crossmark

β-Cyclodextrin-Functionalized Sodium Alginate Nanocarrier Co-Loaded with Naringenin Attenuates Pregnancy-Induced Hypertension Via JAK/STAT3 Pathway Inhibition

Crossref DOI link: https://doi.org/10.1007/s12010-025-05525-5

Published Online: 2026-01-14

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Su, Xiaofeng

Chi, Yichan

Shen, Xiaomiao

Luo, Jieyu

Qiu, Xiaoju https://orcid.org/0009-0001-8900-1039
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-01-14
More Information

Article History

Accepted: 10 December 2025

First Online: 14 January 2026

Declarations

:

: All of the authors concur to take part of this project.

: The research article has been approved for publication by all of the authors. Currently, the manuscript is not being reviewed or published.

: All animal experiments were performed under strict obedience to the animal ethical principles and guidelines of the Chinese Council on Animal Care. All the treatment and testing procedures were approved by the Ethical Committee of Beijing Jinglai Huake Biotechnology Co., Ltd(NO. JLSW-202339).

: No authors have declared a conflict of interest related to this research.

Document is current

Any future updates will be listed below